Clinical observational study on the efficacy of induction chemotherapy sequential concurrent radiotherapy combined with targeted therapy in patients with locally advanced EGFR-positive nasopharyngeal carcinoma: prediction model construction and efficacy testing

被引:0
作者
Yuanyuan Luo
XueJing Xiang
XiaoJie Ma
机构
[1] Affiliated Hospital of North Sichuan Medical College,
[2] North Sichuan Medical College,undefined
来源
European Archives of Oto-Rhino-Laryngology | 2023年 / 280卷
关键词
Nasopharyngeal tumor; Prognosis; Induction chemotherapy sequential concurrent radiotherapy; Targeted therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5409 / 5416
页数:7
相关论文
共 90 条
  • [1] Chen YP(2019)Nasopharyngeal carcinoma Lancet 394 64-80
  • [2] Chan ATC(2018)Incidence and mortality of nasopharyngeal carcinoma in China, 2014 Chin J Oncol 40 566-571
  • [3] Le QT(2019)Current perspectives on nasopharyngeal carcinoma Adv Exp Med Biol 1164 11-34
  • [4] Fu ZT(2021)The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma Cancer Commun 41 1195-1227
  • [5] Guo XL(2021)Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline J Clin Oncol 39 840-859
  • [6] Zhang SW(2019)Chinese expert consensus on diagnosis and treatment of nasopharyngeal carcinoma: evidence from current practice and future perspectives Cancer Manag Res 11 6365-6376
  • [7] Lee HM(2021)Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study Transl Oncol 14 757-763
  • [8] Okuda KS(2019)Treatment of locally advanced nasopharyngeal carcinoma by helical tomotherapy: an observational, prospective analysis Transl Oncol. 12 26-32
  • [9] González FE(2017)Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 614 patients from a single center Oral Oncol 69 127-137
  • [10] Tang LL(2021)Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areas Oral Oncol 115 1040-1049